Inmediate Feeding Tolerance in Acute Pancreatitis
- Conditions
- Acute Pancreatitis Due to Gallstones
- Interventions
- Dietary Supplement: TIME OF FEEDING
- Registration Number
- NCT03354065
- Lead Sponsor
- Hospital Central "Dr. Ignacio Morones Prieto"
- Brief Summary
Objective: Determine tolerance of immediate oral intake (8 hours posterior to the beginning of treatment) against traditional management (early feeding at 48hr) in patients with mild acute pancreatitis of biliary origin.
Double blind, randomized clinical trial
- Detailed Description
The investigators included patients 15 - 85 years old, any sex. Diagnosis of mild acute pancreatitis according to the Ranson, APACHE II and BISAP.
Signed infromed consent to participate in the study. All participants had a hepatic and biliary ultrasound to determine the biliary etiology.
The investigators excluded patients with pancreatitis of nonbiliary etiology, pregnant, severe pancreatitis, cholangitis or choledocholithiasis demonstrated during the hospital stay or with other comorbidities.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 59
Patients older than 15 years.
- Patients with a diagnosis of mild acute pancreatitis biliary.
- Patients who agree to enter the protocol.
-
Patients managed at another institution.
- Patients with a diagnosis of pancreatitis of non-biliary etiology.
- Patients with heart disease or lung disease.
- Patients with organic failure.
- Patients with pregnancy.
- Patients with cholangitis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Early oral feeding TIME OF FEEDING TIME OF FEEDING. 48 hours after pancreatitis general management is started ( liquid diet) Immediate oral feeding TIME OF FEEDING TIME OF FEEDING: 8 hours of after pancreatitis general management is started (enteral formula)
- Primary Outcome Measures
Name Time Method Pancreatitis reactivation after oral Feeding Measures at 48hours after the begining of the oral intake Resurgence of characteristically epigastric tansfictive pain, irradiated to the left, upper quadrant region after beginning the oral intake, systemic inflammatory response syndrome ( C reactive protein) or Significant leucocyte elevation
- Secondary Outcome Measures
Name Time Method